Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$365K Hold
2,768
0.38% 38
2023
Q4
$302K Sell
2,768
-50
-2% -$5.19K 0.32% 38
2023
Q3
$290K Sell
2,818
-50
-2% -$5.39K 0.3% 38
2023
Q2
$331K Sell
2,868
-750
-21% -$85.2K 0.31% 41
2023
Q1
$385K Hold
3,618
0.36% 43
2022
Q4
$401K Hold
3,618
0.39% 43
2022
Q3
$312K Sell
3,618
-68
-2% -$6.07K 0.33% 44
2022
Q2
$336K Hold
3,686
0.32% 48
2022
Q1
$302K Sell
3,686
-200
-5% -$15.8K 0.24% 50
2021
Q4
$298K Hold
3,886
0.2% 51
2021
Q3
$292K Hold
3,886
0.22% 51
2021
Q2
$303K Sell
3,886
-323
-8% -$24K 0.22% 50
2021
Q1
$309K Sell
4,209
-1
-0% -$74 0.23% 52
2020
Q4
$329K Buy
+4,210
New +$322K 0.25% 51
2019
Q2
Sell
-2,593
Closed -$206K 64
2019
Q1
$206K Buy
+2,593
New +$194K 0.17% 63
2017
Q4
Sell
-3,751
Closed -$229K 60
2017
Q3
$229K Hold
3,751
0.2% 60
2017
Q2
$229K Buy
3,751
+32
+0.9% +$1.95K 0.2% 62
2017
Q1
$225K Buy
+3,719
New +$226K 0.2% 65
2016
Q4
Sell
-3,520
Closed -$209K 67
2016
Q3
$209K Buy
+3,520
New +$206K 0.21% 65
2016
Q1
Sell
-3,887
Closed -$196K 68
2015
Q4
$196K Buy
+3,887
New +$196K 0.2% 68
2015
Q3
Sell
-3,803
Closed -$206K 73
2015
Q2
$206K Buy
+3,803
New +$213K 0.19% 70

Other funds holding MRK

Arthur B. Page's MRK Position: Q1 2024 in Review

Arthur B. Page held its Merck (MRK) position steady in Q1 2024 at 2,768 shares worth $365K. The position accounts for 0.38% of the portfolio, ranked #38.

Arthur B. Page first reported a position in MRK in Q2 2015 and has held it in 21 quarters since. The position peaked at $401K in Q4 2022. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Arthur B. Page held 2,768 shares of Merck worth $365K as of Q1 2024.
  • Arthur B. Page left its Merck share count unchanged in Q1 2024.
  • Merck made up 0.38% of Arthur B. Page's portfolio in Q1 2024, its #38 holding.
  • Arthur B. Page first reported a position in Merck in Q2 2015 and has held it in 21 quarters since.
  • Arthur B. Page's Merck position peaked at $401K in Q4 2022.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Arthur B. Page's 13F filing for Q1 2024, filed 29 Apr 2024.